The introduction of a dedicated stroke ambulance housing a small, head CT scanner was an innovation almost ahead of its time when introduced by Fassbender and colleagues in Homburg, more than a decade ago. 1 There is now a quiet revolution occurring with the introduction of numerous mobile stroke units (MSUs) in the northern hemisphere and more recently in Melbourne, Australia and Buenos Aires, Argentina. The momentum is such that the Pre-Hospital Stroke Organization is currently being formed to support the global initiatives, facilitate data sharing with harmonized databases, and provide a solid research base to ensure that evidence drives future developments.
The most significant advantage of the MSU is to treat more patients within the first ''golden hour'' post stroke onset. Our initial experience with the Melbourne MSU shows that the proportion of patients treated within this time-sensitive window has increased from only around 2% prior to introduction of the MSU to 17% after its introduction. Given that this is only within the first six months of the Melbourne MSU experience, it indicates that that the opportunity exists to substantially increase that proportion, given that more than 50% of patients have been treated in this hyperacute time window by our colleagues in Homburg. 2 For patients with intracerebral hemorrhage (ICH), acute blood pressure lowering and reversal strategies for anticoagulant-related ICH can now be used. If validated in clinical trials, future MSU-based use of hemostatic therapies such as recombinant factor VIIa and tranexamic acid could potentially attenuate hematoma growth before hospital arrival.
The confluence of the introduction of stroke telemedicine in many parts of the world, with MSUs is a fortunate one. The opportunity exists to link these two technologies to obviate the need to have a strokologist on board the MSU and make decisions remotely in collaboration with on board emergency ambulance and nursing staff. The underpinning of therapies within the ''golden hour,'' particularly thrombolysis and thrombectomy, is dependent upon these revolutionary technologies, with even more opportunities in the future. Among the most promising, point of care devices to instantaneously transmit critical biological information to hospitals so that the arrival of the patient to emergency departments and stroke units may be even more seamless than is currently the case.
Other point of care developments might be biomarker related to enhance the diagnostic accuracy of the acute event, a real need, particularly in developing countries. Pre-hospital stroke research is an exciting new frontier.
In vast countries such as Canada, the US, China, Russia, Australia, Brazil, and Germany, the prospect of maximizing health care delivery to remote regions exists via the introduction of an air ambulance with on board CT capability.
This concept is also being advanced in Norway because of its often inaccessible communities due to climatic and geographical considerations.
As illustrated in this August 2018 edition of IJS, the face of stroke management is changing even more quickly than we could have ever imagined.
